Bill Sponsors: NY A07533 | 2019-2020 | General Assembly

Bill Title: Requires dihydropyrimidine dehydrogenase deficiency testing prior to fluoropyrmidine or other antimetabolite treatment; requires policies and contracts of insurance to include coverage for dihydropyrimidine dehydrogenase deficiency testing; provides for dihydropyrimidine dehydrogenase deficiency testing under the medical assistance program.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2020-01-08 - referred to health [A07533 Detail]

Text: Latest bill text (Introduced) [HTML]

Sponsors

NameTypeSponsorshipDistrictFinancialEncyclopediaBiography
Assemblymember Patricia Fahy [D]PrimarySponsored BillsHD-109FollowTheMoneyBallotpediaVoteSmart

Social Comments on NY A07533

feedback